Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

Objectives: With human papillomavirus (HPV) testing, patients' HPV status may be known
when reviewing cytology specimens. Methods: 41,955 women 25 years or older had …

Minor cytologic abnormalities of the cervix, such as atypical squamous cells of undetermined
significance (ASCUS), are vastly more common than high-grade squamous intraepithelial …

Human papillomavirus (HPV) is widely accepted as the primary agent involved in the
development of squamous intraepithelial neoplasia and cervical carcinoma. Several …

BACKGROUND Algorithms for primary human papillomavirus (HPV) screening, primary
HPV screening plus cytology cotesting, and cytology alone were evaluated previously in …

Background Cervical cancer screening algorithms are increasingly focused on Human
Papillomavirus (HPV)‐based screening while the accuracy of using abnormal cytological …

Objective: We investigated the potential impact of using the high-risk human papillomavirus
(HPV) test as a primary screening tool for the detection of cervical cancer and its precursor …

Objectives 1) To assess if HPV (human papillomavirus)-DNA testing using the presently
available technology offers any advantage over the utilization of the traditional Pap-smear …

Preview In recent years, guidelines for cervical cytologic screening have been reexamined
and revised. The resulting trend toward less frequent screening for low-risk patients …

BACKGROUND. The purpose of this study was to determine the efficacy of a repeat
Papanicolaou (Pap) smear and the Hybrid Capture tube-based (HCT) HPV DNA test for …